Outcomes | RIB group | SAPB group | PVB group | F/χ2values | P values |
---|---|---|---|---|---|
Intraoperative sufentanil consumption, µg | 0(0,0) | 0(0,5) | 0(0,0) | 15.1 | < 0.001 |
Number of intraoperative sufentanil users, n (%) | 5(11.4%) | 18(40.9%) | 6(13.6%) | 13.88 | < 0.001 |
PACU tramadol, mg | 0(0,0) | 0(0,0) | 0(0,0) | 0.512 | 0.77 |
Postoperative 24-hour tramadol, mg | 0(0,100) | 0(0,100) | 0(0,0) 3 | 6.25 | 0.05 |
Intraoperative hypotension, n (%) | 20(40.6%) | 21(48.8%) | 24(54.5%) | 0.79 | 0.67 |
Intraoperative bradycardia, n (%) | 14(33.3) | 13(31%) | 15(35.7%) | 0.21 | 0.97 |
Intraoperative arrhythmia, n (%) | 0 | 1(2.3%) | 2(4.5%) | 2 | 0.37 |
terms of the time to extubation, min | 5(3,5) | 5(3,6) | 3(2,5.75) | 1.49 | 0.66 |
PONV, n (%) | 5(11.3%) | 12(27.3%) | 6(13.6%) | 4.53 | 0.13 |
Hospital length of stay, days | 14.3 ± 4.3 | 12.75 ± 4.97 | 13.14 ± 3.68 | 1.49 | 0.23 |